Document Type
Essay
Publication Title
Emory Int'l L. Rev. Recent Dev.
Publication Date
1-1-2015
Abstract
In response to the public outcry over the death of millions of people in developing countries because of a lack of access to life-saving drugs, the World Trade Organization (WTO) recognized the need for developing countries to obtain pharmaceutical drugs at a reduced rate. However, the WTO received significant pushback from patent holders and pharmaceutical companies who insisted that their patents be upheld in every country. The dilemma resulted in the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and the 2003 Doha Declaration. Despite these efforts, millions of people are still dying because of a lack of access to pharmaceutical drugs. Arun J. Mohan argues that the only cure for the failure of the TRIPS Agreement and subsequent WTO actions is for the international community to set up a body that oversees the distribution of drugs to developing countries only when national health emergencies occur.
Volume
29
First Page
2001
Recommended Citation
Arun J. Mohan,
Worldwide Accountability: The WTO's Failure To Create an Infrastructure that Delivers Pharmaceutical Drugs to Developing Countries,
29
Emory Int'l L. Rev. Recent Dev.
2001
(2015).
Available at:
https://scholarlycommons.law.emory.edu/eilr-recent-developments/23